Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-08-18 | “Mr. Chimovits earned his M.B.A., M.Sc. in Microbiology and his B.Sc. from Tel Aviv University.” |
| 2018-04-30 | “Erez Chimovits, M.Sc., MBA ... is a Senior Managing Director with OrbiMed ... Prior to joining OrbiMed, he was the Chief Executive Officer of NasVax ... Previously, Mr. Chimovits spent more than seven years with Compugen ... Mr. Chimovits earned his M.B.A., M.Sc. in Microbiology and his B.Sc. from Tel Aviv University.” |
| 2019-05-15 | "Mr. Chimovits is a Senior Managing Director with OrbiMed... Prior to joining OrbiMed, he was the Chief Executive Officer of NasVax Ltd.... He currently serves on the board of LogicBio Therapeutics, Inc.... Mr. Chimovits earned his M.B.A., M.Sc. in Microbiology and his B.Sc. from Tel Aviv University." |
| 2020-03-31 | "Erez Chimovits, M.Sc., MBA has served as a member of our board of directors since May 2017... He is a Senior Managing Director with OrbiMed, a healthcare investment firm..." |
| 2021-04-29 | “Erez Chimovits” appears in the Fiscal Year 2020 Director Compensation Table, but no biographical section for him is included in the filing excerpt provided. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-14